Stability of Insulin in Total Parenteral Nutrition Solutions

  • Kumagai Takefumi
    Pharmacy Co. Ltd.
  • Kihira Yoshitaka
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Fujimura Yoshino
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Miyago Ken
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Katayama Chiaki
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Matsutani Nozomu
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Inoue Hirofumi
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Tsuruta Yasuto
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Yoshitomi Hironori
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Sato Eiji
    Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University

Bibliographic Information

Other Title
  • 中心静脈栄養用輸液に混注されたインスリンの含量変化に関する検討
  • チュウシン ジョウミャク エイヨウヨウユエキ ニ コンチュウ サレタ インスリン ノ ガンリョウ ヘンカ ニ カンスル ケントウ

Search this article

Description

<p>Elneopa NF No. 1 and No. 2 infusions are complete parenteral nutrition solutions packaged as four-chambered bags. They have been used for home parenteral nutrition, with insulin injected into the bags for patients whose blood glucose becomes elevated. In this study, the stability of insulin in No. 1 and No. 2 bags was investigated. The quantity of insulin in Elneopa NF No. 2 was significantly lower than that in Elneopa NF No. 1. When insulin was injected into the upper chamber of either product, decreases in insulin levels were not observed. In contrast, the levels of insulin injected into the lower chamber of both products significantly decreased, with a larger difference in Elneopa NF No. 2. As the amino acid content is different between No. 1 and No. 2, amino acids may be considered a potential cause for the degradation of insulin in the bags. In addition, decreases in insulin levels were observed as the solutions passed through infusion sets just after flushing began, with both Elneopa NF No. 1 and No. 2. In conclusion, the concentration of insulin injected into the Elneopa infusion bags decreases, especially in No. 2 bags, and insulin is absorbed by the infusion sets.</p>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 140 (4), 577-584, 2020-04-01

    The Pharmaceutical Society of Japan

Citations (2)*help

See more

References(9)*help

See more

Details 詳細情報について

Report a problem

Back to top